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Letters to the Editor
Changes to the Diagnostic Criteria for Bipolar
Disorder in DSM-5 Make Little Difference
to Lifetime Diagnosis: Findings From the
U.K. Bipolar Disorder Research Network
(BDRN) Study
TOTHEEDITOR: DSM-5 criterion A formanic and hypomanic
episodes includes the additional requirement of abnormally
and persistently increased activity or energy. This require-
ment was not present in DSM-IV. This update raises the
question ofwhether research groups and consortiawith large
DSM-IV bipolar disorder cohorts can combine these with
DSM-5 cases in ongoing and future analyses.
One study has suggested that considerably fewer indi-
vidual episodes may meet the new DSM-5 criteria for hy-
pomania andmania thanunderDSM-IV(1).The study found
that of 310patients in tertiary carediagnosedwith aDSM-IV
episode of hypomania or mania at time of entry into the
Systematic Treatment Enhancement Program for Bipolar
Disorder (STEP-BD) study, only 52% also met DSM-5 cri-
teria. Interestingly, longitudinal clinical outcomes at 1 year
didnot differ between thosewhodid anddidnotmeetDSM-5
criteria. There have been no studies, however, that have
examined the effect of the change in criteria on lifetime di-
agnosis. We sought to address this question using data from
our large bipolar disorder research cohort.
We have rated the lifetime presence or absence of over-
activity in the context of hypomanic or manic episodes in
3,993 cases with a lifetime diagnosis of DSM-IV bipolar I
disorder (N52,801) and bipolar II disorder (N51,192) in our
U.K. Bipolar Disorder Research Network (BDRN) program.
Cases are recruited systematically through secondary psy-
chiatric care, advertisements on our web site (BDRN.org),
and patient support organizations. Best-estimate main life-
time diagnosis and clinical variables, including the presence
of individualmood symptoms, are rated from semistructured
interview data (Schedules for Clinical Assessment in Neuro-
psychiatry) and available clinical records. Interrater reliability
between the research psychologists and psychiatrists con-
ducting the interview, rating, and diagnostic procedures is high,
with mean kappa statistics of 0.85 for DSM-IV diagnosis and
between0.81and0.99forotherkeyclinicalcategoricalvariables.
We found that 94% and 93% of our cases with a lifetime
DSM-IV diagnosis of bipolar I disorder and of bipolar II
disorder, respectively, experienced overactivity in the con-
text of at least onemanic or hypomanic episode and therefore
would meet lifetime DSM-5 criteria for a bipolar disorder
diagnosis. These ﬁndings are in agreement with a study that
found increased motor activity to be the most frequent
symptomofmania (85%295%of cases) (2). The STEP-BD
study found a much lower level of concordance between
DSM-IV andDSM-5 diagnoses butmeasured only current
symptoms using a clinician-rated monitoring form in cur-
rently unwell participants. We measured lifetime symptoms
based on research interviews with euthymic participants
in addition to available clinical records. Furthermore, the
samples were drawn from different populations and as a
result, there are potential differences in the clinical char-
acteristics of the two samples. It is important to note that we
did notmeasure hypomanic ormanic increased energy in the
BDRNbecause thiswas not part ofDSM-IV criteria for either
a manic or hypomanic episode. Therefore, 94% is an under-
estimation of the true proportion of BDRN participants who
would reach lifetime DSM-5 criteria. Therefore, we are con-
ﬁdent that our sample, and similar samples around the world,
withmain lifetimeDSM-IV diagnoses of bipolar disorder can
be combinedwith lifetimebipolar samples diagnosed according
to DSM-5 in ongoing and future analyses.
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Commentary on the Risk of Treatment-Emergent
Mania With Methylphenidate in Bipolar Disorder
TO THE EDITOR: The article by Alexander Viktorin and col-
leagues (1), published in the April 2017 issue of the Journal,
reported ﬁndings from Swedish national registers regarding
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